207 related articles for article (PubMed ID: 31089234)
1. Vaccination lags behind in middle-income countries.
Berkley S
Nature; 2019 May; 569(7756):309. PubMed ID: 31089234
[No Abstract] [Full Text] [Related]
2. Vaccine candidates for poor nations are going to waste.
Kaslow DC; Black S; Bloom DE; Datla M; Salisbury D; Rappuoli R
Nature; 2018 Dec; 564(7736):337-339. PubMed ID: 30560957
[No Abstract] [Full Text] [Related]
3. Vaccine progress reveals resource gaps in developing countries.
Burki TK
Lancet Infect Dis; 2011 Mar; 11(3):165-6. PubMed ID: 21491698
[No Abstract] [Full Text] [Related]
4. Global vaccine project gets a shot in the arm.
Check E
Nature; 2005 Jan; 433(7024):345. PubMed ID: 15674258
[No Abstract] [Full Text] [Related]
5. Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.
Haakenstad A; Birger M; Singh L; Liu P; Lim S; Ng M; Dieleman JL
Health Aff (Millwood); 2016 Feb; 35(2):242-9. PubMed ID: 26858376
[TBL] [Abstract][Full Text] [Related]
6. Income Elasticity of Vaccines Spending versus General Healthcare Spending.
Alfonso YN; Ding G; Bishai D
Health Econ; 2016 Jul; 25(7):860-72. PubMed ID: 26010073
[TBL] [Abstract][Full Text] [Related]
7. Make vaccine coverage a key UN health indicator.
Berkley S
Nature; 2015 Oct; 526(7572):165. PubMed ID: 26450023
[No Abstract] [Full Text] [Related]
8. COP24 and SDGs - use same statistics please.
Tubiello FN
Nature; 2018 Dec; 564(7735):190. PubMed ID: 30531885
[No Abstract] [Full Text] [Related]
9. Drive to vaccinate children in developing countries faces "acute crisis" because of high costs.
Moszynski P
BMJ; 2010 May; 340():c2576. PubMed ID: 20462931
[No Abstract] [Full Text] [Related]
10. Cash crisis looms for vaccine drive.
Butler D
Nature; 2010 Mar; 464(7287):338. PubMed ID: 20237535
[No Abstract] [Full Text] [Related]
11. Putting your money where your mouth is: Geographic targeting of World Bank projects to the bottom 40 percent.
Öhler H; Negre M; Smets L; Massari R; Bogetić Ž
PLoS One; 2019; 14(6):e0218671. PubMed ID: 31226139
[TBL] [Abstract][Full Text] [Related]
12. Modern vaccines. Progress towards vaccines we need and do not have.
Robbins A
Lancet; 1990 Jun; 335(8703):1436-8. PubMed ID: 1972216
[No Abstract] [Full Text] [Related]
13. WHO expectation and industry goals.
Vandersmissen W
Vaccine; 2001 Feb; 19(13-14):1611-5. PubMed ID: 11166883
[TBL] [Abstract][Full Text] [Related]
14. Win-win interactions between the public and private sectors.
Batson A
Nat Med; 1998 May; 4(5 Suppl):487-91. PubMed ID: 9585192
[No Abstract] [Full Text] [Related]
15. Immunization needs a technology boost.
Berkley S
Nature; 2017 Nov; 551(7680):273. PubMed ID: 29144479
[No Abstract] [Full Text] [Related]
16. Vaccine visions and their global impact.
Bloom BR; Widdus R
Nat Med; 1998 May; 4(5 Suppl):480-4. PubMed ID: 9585190
[No Abstract] [Full Text] [Related]
17. Challenges and Opportunities to Realize "The 2030 Agenda for Sustainable Development" by the United Nations: Implications for Radiation Therapy Infrastructure in Low- and Middle-Income Countries.
Datta NR; Rogers S; Bodis S
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):918-933. PubMed ID: 31451317
[TBL] [Abstract][Full Text] [Related]
18. The global vaccine enterprise: a developing world perspective.
Shin SI
Nat Med; 1998 May; 4(5 Suppl):503-5. PubMed ID: 9585198
[No Abstract] [Full Text] [Related]
19. The global value of vaccination.
Ehreth J
Vaccine; 2003 Jan; 21(7-8):596-600. PubMed ID: 12531324
[TBL] [Abstract][Full Text] [Related]
20. Valuing childhood vaccines.
Davis MM; Kemper AR
J Pediatr; 2003 Sep; 143(3):283-4. PubMed ID: 14517503
[No Abstract] [Full Text] [Related]
[Next] [New Search]
